# PROCRIT and Short-Term Outcomes in Orthopedic Surgery

> **NCT00236405** · PHASE2 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 6 (actual)

## Conditions studied

- Anemia
- Surgery, Arthroscopy

## Interventions

- **DRUG:** epoetin alfa

## Key facts

- **NCT ID:** NCT00236405
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The study was terminated due to poor enrollment.
- **Last updated:** 2011-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236405, "PROCRIT and Short-Term Outcomes in Orthopedic Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00236405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*